Millennium Pharmaceuticals

• Founded

  1 Jan 1993

Sources: ror.org

• NCT03849690

  Phase 1, Completed, 12 people, 21 Feb 2019

• NCT03708211

  Phase 1, Completed, 20 people, 17 Oct 2018

• NCT03486314

  Phase 1, Completed, 20 people, 3 Apr 2018

• NCT03439280

  Phase 1/2, Completed, 50 people, 20 Feb 2018

• NCT03330106

  Phase 1, Completed, 68 people, 6 Nov 2017

• NCT03236792

  Collaborator, Phase 1/2, Completed, 28 people, 2 Aug 2017

• NCT03170882

  Phase 2, Completed, 122 people, 31 May 2017

• NCT03057366

  Phase 1, Completed, 8 people, 20 Feb 2017

• NCT02988986

  Collaborator, Phase 2, Completed, 28 people, 12 Dec 2016

• NCT02954406

  Phase 1, Terminated, 43 people, 3 Nov 2016

• NCT02831686

  Collaborator, Phase 1, Completed, 18 people, 13 Jul 2016

• NCT02765854

  Collaborator, Phase 2, Completed, 70 people, 9 May 2016

• NCT02724020

  Phase 2, Completed, 96 people, 31 Mar 2016

• NCT02700022

  Collaborator, Phase 1, Terminated, 1 person, 7 Mar 2016

• NCT02697383

  Collaborator, Phase 1, Completed, 14 people, 3 Mar 2016

• NCT02686346

  Collaborator, Phase 1/2, Completed, 53 people, 19 Feb 2016

• NCT02575339

  Collaborator, Phase 1/2, Terminated, 11 people, 14 Oct 2015

• NCT02535806

  Collaborator, Phase 2, Terminated, 2 people, 31 Aug 2015

• NCT02516423

  Collaborator, Phase 3, Terminated, 11 people, 5 Aug 2015

• NCT02484261

  Collaborator, Phase 1, Terminated, 10 people, 29 Jun 2015

• Biomarkers of Cellular Senescence and their Association with Frailty, Clinical Outcomes, and Survival in Multiple Myeloma

  Consulting or advice, Grants or research support, 19 Mar 2026

Sources: pubmed.ncbi.nlm.nih.gov